Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04698213 |
| Title | Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A) |
| Acronym | TIDE-A |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Consorzio Oncotech |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |